Home › Funds › Syverson Strege & Co › JNJ

Syverson Strege & Co position in JNJ

JOHNSON & JOHNSON · Health Care

Syverson Strege & Co reported holding 6,445 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 0.39% of its reported portfolio and ranking #30 among its reported holdings. Syverson Strege & Co has disclosed JNJ holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)6.45K sh
Reported value held$1.71M
Portfolio Weight0.39%
First reportedQ1 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Syverson Strege & Co's JNJ position evolved

Syverson Strege & Co first disclosed a stake in JNJ in Q1 2024 at 1,425 shares (US$225K). The position peaked in Q3 2026 at 6,445 shares, worth US$1.7M. Across 11 filings, Syverson Strege & Co increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,445 shares valued at US$1.7M — an increase of 142 shares quarter over quarter.. Notable position changes include a 64% increase in Q2 2024 (shares rose 11% over the following quarter), a 43% trim in Q3 2024 (shares fell 11% over the following quarter), a 335% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.43K $225.50K New
Q2 2024 2.33K $341.03K Add
Q3 2024 1.33K $215.38K Reduce
Q4 2024 1.39K $201.62K Add
Q1 2025 1.50K $248.73K Add
Q2 2025 6.53K $996.66K Add
Q3 2025 6.40K $1.19M Reduce
Q4 2025 6.62K $1.37M Add
Q1 2026 6.54K $1.60M Reduce
Q2 2026 6.30K $1.60M Reduce
Q3 2026 6.45K $1.71M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Syverson Strege & Co held JNJ?

Syverson Strege & Co has disclosed JNJ holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Syverson Strege & Co's current position in JNJ?

As of Q3 2026, Syverson Strege & Co holds 6.45K shares of JNJ (JOHNSON & JOHNSON), valued at $1.71M, representing 0.39% of its reported portfolio and ranking #30.

Has Syverson Strege & Co been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Syverson Strege & Co increased its position in JNJ. The position peaked in Q3 2026 at 6.45K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.